Morning Light Therapy for Inflammatory Bowel Disease

This trial tests whether morning light therapy can help adults with ulcerative colitis, a type of inflammatory bowel disease, who also have trouble sleeping. The aim is to determine if this therapy can improve sleep quality and reduce inflammation. Participants will use morning light therapy for an hour each day while tracking their sleep and symptoms. The trial seeks individuals with ulcerative colitis experiencing active inflammation and poor sleep. As an unphased trial, it offers a unique opportunity to explore a novel approach to managing symptoms and improving quality of life.

You may need to stop taking certain medications, especially those affecting sleep or the autonomic nervous system, like beta-blockers, benzodiazepines, and sleep medications. If you regularly use these, you might need a 4-week period without them before joining the study.

Research has shown that morning light therapy (MLT) is generally safe and well-tolerated for people with inflammatory bowel disease (IBD), including ulcerative colitis (UC). Studies have found MLT to be a practical and acceptable treatment option. No major reports of serious side effects have emerged from this therapy. Most patients manage the therapy without significant problems, suggesting it could be a good choice for those seeking alternative ways to manage their symptoms.¹²³⁴⁵

Unlike the standard treatments for ulcerative colitis, which often include medications like aminosalicylates, corticosteroids, or immunosuppressants, morning light therapy offers a novel, non-drug approach. Researchers are excited about this treatment because it harnesses natural light exposure to potentially regulate the body's circadian rhythms and reduce inflammation. This could provide a gentler alternative with fewer side effects, offering hope for those who struggle with the side effects of traditional medications.

Research suggests that morning light therapy, which participants in this trial will receive, can help individuals with inflammatory bowel disease (IBD), such as ulcerative colitis, by improving symptoms and reducing disease activity. Morning light resets the body's internal clock, potentially enhancing sleep and reducing inflammation. Studies have shown that this therapy eases symptoms by aligning sleep patterns with natural light cycles. As a result, patients might experience less inflammation and better overall health. Although more research is needed, early findings are encouraging.¹²³⁵⁶